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background
Chronic infection with cytomegalovirus (CMV), Chlamydia pneumoniae, 
herpes simplex virus 1 (HSV-1), and Helicobacter pylori may contribute 
to essential hypertension. However, the evidence now available does 
not clarify whether the aggregate number of pathogens (pathogen 
burden) may be associated with hypertension.
methods
Sera from 1,754 men and women aged ≥25  years were analyzed for 
immunoglobulin G antibodies to C.  pneumoniae, HSV-1, H.  pylori, 
and CMV using enzyme-linked immunosorbent assay. The aggregate 
number of seropositives to the studied viral and bacterial agents was 
defined as pathogen burden. Hypertension was defined according to 
World Health Organization criteria.
results
A total of 459 (26.3%) of the subjects had hypertension. In the hyper-
tensive group, 4.2% had 0 or 1 pathogens present, 20.6% had 2, 43.2% 
had 3, and 32.1% had 4; in the normotensive group, 7.9% had 0 or 1, 
28.4% had 2, 42.7% had 3, and 21.0% had 4. Of the 4 studied pathogens, 
H.  pylori seropositivity showed a significant independent association 
with hypertension (odds ratio (OR) =1.37; 95% confidence interval 
(CI) =1.05–1.79; P = 0.02). In multiple logistic regression analyses, the 
pathogen burden did not show a significant independent associa-
tion with hypertension. Coinfection with H.  pylori and C.  pneumoniae 
was significantly associated with hypertension compared with double 
seronegativity after adjustment for age, sex, chronic low-grade inflam-
mation, and cardiovascular risk factors (OR = 1.68; 95% CI = 1.14–2.47; 
P = 0.008].
conclusions
The pathogen burden was not associated with hypertension. However, 
coinfection with C. pneumoniae and H. pylori showed a significant asso-
ciation with essential hypertension, independent of cardiovascular risk 
factors and chronic low-grade inflammation.
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Chronic infection with Chlamydia pneumoniae, Helicobacter 
pylori, and persistent viruses such as herpes simplex virus 1 
(HSV-1) and cytomegalovirus (CMV) has gained consider-
able interest as a contributing factor in atherosclerosis.1–3
More recently, the results of some seroepidemiological 
and prospective cohort studies showed that the aggregate 
number of pathogens (infectious burden), rather than any 
single organism, may contribute to coronary artery disease1,4 
and stroke.5 This concept has been referred to as pathogen 
burden (infectious burden).6
The evidence now available does not clarify whether 
pathogen burden per se may be involved in atherosclerosis 
either through induction of an inflammatory and procoagu-
lant milieu in the vessels or through the indirect effects of 
cytokines or acute phase proteins, promoted by pathogens at 
“nonvessel” sites. 2,3,6
Interestingly, beyond the known traditional risk factors 
for hypertension, chronic infection with CMV7,8, C.  pneu-
moniae,9–11, HSV,12 and H.  pylori 13,14 has recently been 
reported in association with high blood pressure, suggesting 
that pathogens may contribute to essential hypertension.
The synergistic effects of multiple infectious agents in 
atherosclerosis poses new questions about the link between 
the aggregate numbers of pathogens to which an individual 
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has been exposed and hypertension. In parallel to work link-
ing pathogen burden to cardiovascular disease, Liu et al.15 
showed that essential hypertension was associated with the 
aggregate pathogens in a cross-sectional study. However, the 
results of that study have not yet been evaluated in further 
investigations.
Therefore, we investigated the association of pathogen 
burden and hypertension, regarding other cardiovascular 
risk factors, in a large-scale, community-based study in an 
Iranian population.
METHODS
Community sampling and baseline examinations
We conducted this study as part of the Persian Gulf Healthy 
Heart Study, which was a prospective, population-based, 
cohort study started in 2003–2004 using men and women 
aged >25 years. Detailed information about the methods and 
procedures of this study is available elsewhere.16
In a study ancillary to the Persian Gulf Healthy Heart 
Study, a total of 1,754 subjects (49.2% male, 50.8% female) 
were selected through a stratified multistage design process 
from major ports of Bushehr Province (the Iranian province 
having the greatest border with the Persian Gulf). All sub-
jects were asked to fast and to present to the survey center 
between 7:30 am and 9:30 am. After a 15-minute rest in the 
sitting position, blood pressure was assessed twice at the right 
arm using a standard mercury sphygmomanometer. Height 
and weight were measured using a stadiometer. Heavy outer 
garments and shoes were removed before measuring height 
and weight. Body mass index (BMI) was calculated.
Biochemical and serologic measurements
A fasting blood sample was taken, and all samples were 
promptly centrifuged, separated, and analyzed at the Persian 
Gulf Health Research Center on the day of blood collection 
using a Selectra 2 autoanalyzer (Vital Scientific, Spankeren, 
the Netherlands).
Glucose was assayed by the enzymatic (glucose oxidase) 
colorimetric method using a commercial kit (Pars Azmun, 
Tehran, Iran). Serum total cholesterol and high-density lipo-
protein cholesterol were measured using a cholesterol oxidase 
phenol aminoantipyrine, and triglycerides were measured 
using a glycerol-3 phosphate oxidase phenol aminoantipyrine 
enzymatic method. Serum low-density lipoprotein (LDL) 
cholesterol was calculated using the Friedwald formula; LDL 
cholesterol was not calculated when triglycerides concentra-
tion was >400 mg/dl. Measurement of CRP was performed by 
a high-sensitivity  C-reactive protein (hs-CRP) assay, CRP HS 
ELISA (DRG International, Springfield, New Jersey, USA).
Immunoglobulin G (IgG) antibodies against C.  pneu-
moniae were measured by a commercial test kit (DRG 
Instruments, Marburg, Germany). The principle of the kit 
was based on an indirect solid-phase enzyme immunoassay 
with horseradish peroxidase as a marker enzyme; the posi-
tivity threshold was enzyme immuno-units >45. Sera were 
screened for IgG antibodies against HSV, CMV, and H. pylori 
with an enzyme-linked immunosorbent assay kit (Radim 
SpA, Pomezia RM, Italy), and the samples were considered 
positive with IgG values >30 RU/ml for CMV and H. pylori. 
Samples with optical density higher than the cutoff control 
were considered reactive for anti-HSV type 1 IgG antibodies.
Definitions
Hypertension was defined according to World Health 
Organization criteria (systolic blood pressure ≥140 mm Hg, 
diastolic blood pressure ≥90 mm Hg, or use of antihyperten-
sive medication).17 The mean arterial pressure was estimated 
using conventional formula: mean arterial pressure  =  (2 
diastolic blood pressure + systolic blood pressure)/3.18 Using 
American Diabetes Association criteria, a fasting plasma 
glucose of ≥126 mg/dl or the use of antidiabetic measures 
was defined as diabetes.19 The cutoff points of serum total 
cholesterol, high-density lipoprotein cholesterol, and LDL 
cholesterol distributions used to assign subjects to differ-
ent levels of risk were derived from the National Cholesterol 
Education Program guidelines in the United States (Adult 
Treatment Panel III).20 Smoking was considered to be pre-
sent when the participant smoked cigarettes or used a shisha 
(water pipe) daily.
The aggregate number of seropositives to C. pneumoniae, 
H. pylori, cytomegalovirus, or HSV-1 was defined as patho-
gen burden.6,21
Statistical methods
Normal distribution of the data was controlled with the 
Kolmogorov–Smirnov test. The significance of the difference 
in results of any 2 groups was determined by χ2 analysis using 
2 × 2 contingency tables for categorical variables. A 2-tailed 
t test was used to compare mean values across groups. We 
found that log transformation of hs-CRP gave a better fit to a 
Gaussian distribution. The geometric mean for hs-CRP was 
defined as the arithmetic mean of the log-transformed data 
± 2 standard deviations, raised to the power of 10.
Binary logistic regression models were used to assess 
association between IgG seropositivities to common bacte-
rial and viral agents, pathogen burden (4, 3, or 2 pathogens 
vs. 0 or 1 pathogen) or coinfections and hypertension (as a 
dependent variable). Further, the models were adjusted for 
BMI, smoking, log-transformed CRP levels, type 2 diabetes 
mellitus, high triglycerides, low high-density lipoprotein 
cholesterol, and high LDL cholesterol in addition to age 
and sex. Known risk factors for cardiovascular diseases and 
characteristics related to hypertension were considered to be 
potential confounders and examined for inclusion in multi-
variable models.
The models’ fits were measured with the Hosmer–
Lemeshow statistic. The overall predictive ability of the 
models was assessed by use of the area under the receiver 
operating characteristic curve.
There were no significant interactions between seroposi-
tivities to pathogens and cardiovascular risk factors (e.g., 
obesity) with hypertension. Therefore, we didn’t include 
these interaction terms in our final models.
Multiple linear regression models were used to assess 
the association between pathogen burden (independent 
1142 American Journal of Hypertension 26(9) September 2013
Vahdat et al.
variables) and the estimated mean arterial pressure 
(dependent variable). Probability values <5% were 
considered statistically significant. All statistical analyses 




A total of 1,754 subjects (49.2% men, 50.8% women) aged 
25–66 years were evaluated for associations of pathogen bur-
den and hypertension. Mean age of participants was 40.79 
(SD = 11.15) years.
Relevant anthropometric information including cardio-
vascular risk factors, biochemical measurements, and the 
prevalence o IgG antibodies against CMV, HSV, C. pneumo-
niae, and H. pylori are presented in Table 1.
Men had higher systolic (117.3 ± 10.7 vs. 113.22 ± 11.1 mm 
Hg) and diastolic blood pressure (74.3 ± 8.2 vs. 73.1 ± 7.7 mm 
Hg) than women (P  <  0.0001). A  total of 459 (26.3%) 
subjects (30.8% of men and 21.8% of women; P < 0.0001) 
had hypertension.
The prevalence of IgG antibodies against CMV (P = 0.004), 
C. pneumoniae (P < 0.0001), and H. pylori (P < 0.0001) was 
higher in the hypertensive group than in healthy persons. 
However, there was no statistically significant difference in the 
prevalence of IgG antibodies against HSV between normoten-
sive and hypertensive individuals (P = 0.29) (Table 1). Women 
also had significantly higher seropositivity for HSV (P = 0.004) 
but lower seropositivity for C. pneumoniae (P < 0.0001) than 
men. However, there were no statistically significant dif-
ferences in the prevalence of IgG antibodies against CMV 
(P = 0.07) and H. pylori (P = 0.20) between men and women.
In the hypertensive group, 4.2% had 0 or 1 pathogens pre-
sent, 20.6% had 2, 43.2% had 3, and 32.1% had 4; in the nor-
motensive group, 7.9% had 0 or 1, 28.4% had 2, 42.7% had 3, 
and 21.0% had 4. There was a marginally significant differ-
ence in the prevalence of number of pathogens between men 
and women (P = 0.04).
Association between single pathogen and hypertension
The age- and sex-adjusted odds ratio (ORs) between 
IgG seropositivity for C.  pneumoniae, H.  pylori, or CMV 
and hypertension was significant (P < 0.05); however, only 
Table 1. Clinical characteristics and laboratory values of a random population of the northern Persian Gulf (the study population) according 
to blood pressure status
Normotensive (n = 1,295) Hypertensive (n = 459)
P valueaMen Women Men Women
Age groups, years, %
 25–34 43.8 46.1 18.5 14.4 <0.0001
 35–44 33.5 30.5 24.9 21.1
 45–54 15.8 16.7 27.9 38.1
 55–66 6.9 6.6 27.9 25.3
Body mass index, kg/m2 25.2 (4.1) 27.7 (5.4) 27.8 (5.2) 30.7 (6.0) <0.0001
Total cholesterol, mg/dl 194.7 (44.4) 203.4 (46.5) 217.0 (47.3) 234.7 (48.9) <0.0001
HDL cholesterol, mg/dl 41.1 (20.6) 48.8 (47.3) 42.0 (47.4) 45.3 (12.7) 0.17
LDL cholesterol, mg/dl 119.1 (42.4) 124. 3 (60.3) 134.7 (61.7) 150.3 (43.2) <0.0001
Triglycerides, mg/dl 172.1 (106.5) 150.93 (91.5) 201.3 (11.9) 195.2 (99.3) <0.0001
Fasting blood sugar, mg/dl 87.7 (29.8) 89.4 (40.2) 99.7 (46.1) 106.6 (54.0) <0.0001
Smoking, % 36.4 20.4 36.6 26.8 0.06
Physical inactivity, % 68.9 76.1 68.3 62.4 0.005
Obesity, % 9.4 30.9 29.4 53.6 <0.0001
High total cholesterol, % 16.0 20.1 27.9 40.2 <0.0001
Low HDL-cholesterol, % 56.9 38.1 60.0 37.6 0.17
High triglycerides, % 50.0 40.6 62.6 60.3 <0.0001
Chlamydia pneumoniae seropositive, % 42.4 34.0 54.0 42.3 <0.0001
Helicobacter pylori seropositive, % 60.2 57.9 69.4 68.0 <0.0001
Cytomegalovirus seropositive, % 90.6 93.5 95.5 96.9 0.004
Herpes simplex virus type 1 seropositive, % 83.1 87.7 84.8 91.5 0.29
Values are mean (SD), except for those indicated as being %. Hypertension was defined according to the World Health Organization.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.
aP values indicate statistical significance of various clinical and biochemical indices between normotensive and hypertensive subjects.
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H.  pylori seropositivity retained its significant associa-
tion with hypertension after adjusting for sex, age, dyslipi-
demia, smoking, type 2 diabetes mellitus, BMI, and hs-CRP 
(OR  =  1.37; 95% confidence interval (CI)  =  1.05–1.79; 
P = 0.02) (Table 2).
Association between pathogen burden and hypertension
The association between age- and sex-adjusted infectious 
burden for 4 pathogens, compared with 0 or 1 pathogen, and 
hypertention was significant; however, this association was 
lost with further adjustments for cardiovascular risk factors 
(Table 2).
In multiple logistic regression analyses, the pathogen bur-
den did not show a significant association with hypertension 
after adjusting for sex, age, dyslipidemia, smoking, type 2 
diabetes mellitus, BMI, and hs-CRP (Table 2).
In linear regression analyses, age-adjusted pathogen bur-
den did not show significant correlations with the estimated 
mean arterial pressure in both men (β = 0.05; P = 0.12) and 
women (β = 0.01; P = 0.61) (Figure 1).
Association between coinfection with H. pylori and 
C. pneumoniae, CMV, or HSV and hypertension
Age- and sex-adjusted coinfection with H.  pylori and 
C.  pneumoniae was significantly associated with hyperten-
sion compared with double seronegativity (OR = 1.73; 95% 
CI = 1.23–2.42; P = 0.002). After adjustment for cardiovascular 
risk factors, including hs-CRP levels, the significant associa-
tion of this coinfection remained (OR = 1.68; 95% CI = 1.14–
2.47; P = 0.008) (Table 2). However, H.pylori seropositivity in 
combination with CMV or HSV seropositivity was not associ-
ated with hypertension in regression models (Table 2).
DISCUSSION
In this large, population-based study, there was no inde-
pendent association between hypertension and the burden 
of common viral and bacterial pathogens that had been pre-
viously associated with coronary artery disease as well as 
carotid atherosclerosis. However, coinfection with C. pneu-
moniae and H. pylori was associated with high blood pres-
sure, independent of cardiovascular risk factors and chronic 
low-grade inflammation.
The mechanisms by which infectious agents may con-
tribute to atherosclerosis include infection-induced auto-
immune response due to microbial molecular mimicry, 
enhanced uptake of cholesterol and of modified LDL choles-
terol, augmentation of procoagulant and proinflammatory 
activities, endothelial dysfunction, alteration of apoptosis, 
and increased expression of adhesion molecules and scav-
enger receptors.1–3,6
According to a pathogen burden model, the greater the 
number of bacterial pathogens such as H. pylori and C. pneu-
moniae and exposures during one’s lifetime to persistent 
viruses such as HSV and CMV, the higher the chance of ath-
erosclerosis and its thrombotic complications that should be 
anticipated.1,22,23 The impact of viral and bacterial infectious 
burden on long-term prognosis in patients with coronary 
artery disease1,4 and stroke5 has already been shown.
Evidence for the existence of a potential link between 
chronic low-grade inflammation and hypertension is grow-
ing.24 Thus, it is plausible that pathogen burden would 
Table 2. Prediction of hypertension by isolated pathogen seropositivity, pathogen burden, and coexisting infections using multivariable odds 
ratios and their 95% confidence intervals
Adjusted for age and sex Adjusted for full modela
OR 95% CI P value OR 95% CI P value
C. pneumoniae 1.35 1.07–1.70 0.01 1.22 0.94–1.58 0.12
H. pylori 1.31 1.03–1.67 0.03 1.37 1.05–1.79 0.02
CMV 1.79 1.04–3.08 0.03 1.76 0.97–3.17 0.06
HSV-1 0.94 0.66–1.34 0.74 0.95 0.65–1.40 0.81
2 pathogensb 1.15 0.64–2.07 0.63 0.93 0.48–1.78 0.93
3 pathogensb 1.34 0.76–2.35 0.30 1.13 0.60–2.11 0.70
4 pathogensb 1.87 1.05–3.34 0.03 1.51 0.79–2.87 0.21
H. pylori + C. pneumoniae 1.73 1.23–2.42 0.002 1.68 1.14–2.47 0.008
H. pylori + CMV 1.31 0.91–1.89 0.14 1.28 0.86–1.90 0.22
H. pylori + HSV-1 1.01 0.76–1.31 0.97 0.97 0.72–1.31 0.89
The Hosmer–Lemeshow statistics were from 4.5 (P = 0.81) to 10.96 (P = 0.20), indicating good levels of fit for all models. The area under the 
receiver operating characteristic curves for the models were from 0.7847 to 0.8165.
Abbreviations: C.  pneumonia, Chlamydia pneumoniae; CMV, cytomegalovirus; H.  pylori, Helicobacter pylori; HSV, herpes simplex virus 
type 1.
aFull model included age, sex, smoking, body mass index, and type 2 diabetes mellitus, high triglyceride, low high-density lipoprotein choles-
terol cholesterol, high low-density lipoprotein cholesterol, and log-transformed high-sensitivity C-reactive protein (hs-CRP) levels.
bVersus 0 or 1 pathogen.
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contribute to the risk of hypertension through infection-
induced inflammatory response.
In contrast with the results of our study, in a cross-sec-
tional study of 488 hypertensive and 942 normotensive 
Chinese Mongolian subjects, pathogen burden was associ-
ated with essential hypertension, whether adjusted by car-
diovascular risk factors or not.15
Discrepancies between that study and our study might be 
due to differences in socioeconomic status, race/ethnicity, 
and the microorganisms studied. The study defined infec-
tious burden as seropositives to C. pneumoniae, M. pneumo-
niae, H.  pylori, and Coxsackie virus.15 Therefore, the topic 
of pathogen burden in essential hypertension seems to be 
ill-defined and merits further studies.
The results of available studies for C.  pneumoniae, 
H. pylori, HSV-1, and CMV in relation to hypertension are 
presented in Table 3.
In our study and the Liu et al. study,15 the significant asso-
ciation between C. pneumoniae and hypertension was atten-
uated after further adjustment for cardiovascular risk factors. 
Conflicting data exist regarding C. pneumoniae in relation to 
hypertension. Some investigators reported a positive rela-
tionship between seropositivity to C. pneumoniae and hyper-
tension.9,11 However, others found no relationship,25,26or else 
an inverse association of C. pneumoniae infection with high 
blood pressure.27
Herpes virus infections have been reported in association 
with human atherosclerosis in different types of studies.28,29 
In the Cardiovascular Health Study, seropositivity to HSV-1 
was associated with a 2-fold increase in the risk of incidents 
of myocardial infarction and coronary heart disease death in 
older adults.29
There are several studies in the medical literature on the 
relationship of herpes virus infection to hypertension. In 
our study, we did not find a significant association between 
the presence of IgG antibodies to HSV-1 and hypertension. 
Kristensen et al.30reported an incremental trend toward HSV 
antibody positivity among subjects in different stages of 
hypertension. In a histopathological study,28 herpes viral DNA 
was significantly associated with arterial hypertension. In a 
cross-sectional study, after adjustment for confounding fac-
tors, an association was found between HSV-2 infection and 
essential hypertension.12 HSV-induced vascular inflammation 
and arterial wall thickening leading to the resistance of blood 
vessels were postulated as the underlying mechanisms.12
Likewise, little is known about CMV’s role as a potential 
risk factor for hypertension.7,8,31 In an in vivo experimen-
tal study, Cheng et al.31 showed that CMV infection alone 
Figure 1. Age-adjusted estimated mean arterial pressure (estimated marginal means ± SE) across pathogen burden in men and women.
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caused a significant increase in arterial blood pressure. They 
also demonstrated that CMV infection activates overexpres-
sion of renin and angiotensin II in blood and in vessel cells 
in a persistent infection manner.31
In our study, we found a negligible, marginal association 
between the presence of IgG antibodies for CMV and hyper-
tension, even when adjusting for atherosclerotic risk factors. 
But, this association was markedly attenuated by including 
hs-CRP in regression models. In a recent study from the 
United States National Health and Nutrition Examination 
Survey, CMV seropositivity was associated with hyperten-
sion in women; however, the association was not significant 
after adjusting for age.7 In the Cardiovascular Risk in Young 
Finns Study, when considering traditional atherosclerotic 
risk factors, high CMV antibody titers were determinants for 
systolic and diastolic blood pressure elevation and brachial 
artery flow-mediated dilation in young men.8 Regarding 
these conflicting human studies, we note a need for a com-
plex approach that includes a package of new atherosclerotic 
risk factors to elucidate CMV’s role in hypertension.
Our study revealed a significant association between IgG 
seropositivity for H. pylori and hypertension. This association 
was retained even after adjustment for conventional risk factors 
for coronary artery disease. Our findings are consistent with 
1 study showing a significant relationship between H.  pylori 
infection and hypertension.13 A  significant decrease in blood 
pressure values, in particular in diastolic blood pressure values, 
was observed after eradication of H. pylori in patients affected 
by hypertension.32 However, the results of a community-based, 
cross-sectional study indicated that H. pylori infection might not 
be a clinically significant associated factor for hypertension.33
The mechanism underlying the association of H.  pylori 
infection and hypertension remains to be elucidated. A posi-
tive relationship between high salt intake and H. pylori infec-
tion was found in a multinational study.34
In a Swedish study of a defined population, subjects with 
combined positive serology for H.  pylori and C.  pneumo-
niae were characterized by lower social class and higher age, 
BMI, and fasting levels of insulin than the group without any 
positive serology.35 The synergy of these 2 infections in the 
development of hypertension has not been investigated so 
far. However, seropositivity for these 2 organisms predicted 
increased risk of coronary artery disease, myocardial infarc-
tion, and higher CRP levels.36
Interestingly, we found that combined seropositivity 
for H.  pylori and C.  pneumoniae, compared with double 
Table 3. Available studies for Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus type 1 (HSV-1), and cytomegalovirus (CMV) 
in relation to hypertension
Pathogen Investigators Type of study
Number of  
participants Relationship
C. pneumonia
Liu et al.15 Cross-sectional survey 1,430 No
Pitiriga et al.9 Case–control 170 Yes
Blanc et al.10 Cross-sectional, population-based 1,304 Yes
Cook et al.11 Case–control 246 Yes
Coles et al.25 Cross-sectional, population-based 1,034 No
Koh et al.26 Cross-sectional, population-based 1,068 No
Nishimura et al.27 Case–control 229 Inverse
Vahdat et al. (this study) Cross-sectional, population-based 1,754 No
HSV-1
Kristensen et al.30 Case–control 186 Yes
Sun et al.12 Case–control 1,244 Yes
Ibrahim et al.28 Histopathological study 48 Yes
Vahdat et al. (this study) Cross-sectional, population-based 1,754 No
CMV
Cheng et al.31 In vivo Yes
Li et al.7 Cross-sectional, population-based 6,303 No in men Yes in women
Haarala et al.8 Cross-sectional, population-based 1,931 Yes
Vahdat et al. (this study) Cross-sectional, population-based 1,754 Yes
H. pylori
Lip et al.13 Case–control 162 Yes
Community-based, cross-sectional 4,900 No
Vahdat et al. (this study) Cross-sectional, population-based 1,754 Yes
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seronegativity, was independently associated with hyper-
tension. Statistically, the contribution of this coinfection to 
hypertension was more pronounced than H. pylori IgG sero-
positivity alone. The H. pylori infection in combination with 
CMV or HSV-1 did not show a significant association with 
hypertension in this study. Hence, these findings may sug-
gest a unique synergy of this coinfection in the development 
of hypertension, rather than the concept of pathogen burden 
in essential hypertension.
Shumacher et  al.37demonstrated that coinfection with 
H.  pylori and C.  pneumoniae in patients with coronary 
artery disease was associated with elevated levels of solu-
ble intercellular cell adhesion molecule-1 (sICAM-1) when 
compared with double seronegativity, which supports our 
findings. They also observed elevated levels of soluble vas-
cular cell adhesion molecule 1 in this coinfection compared 
with those who were only C.  pneumoniae immunoglobu-
lin A  positive, indicative of aggravation of the endothelial 
inflammatory response.37 Additionally, Liuba et al. 38showed 
that coinfection of apolipoprotein E-knockout mice with 
H. pylori and C. pneumoniae was associated with enhanced 
expression of VCAM-1 at the branching sites and impaired 
endothelial vasomotor function of thoracic aortas.
Our study has several limitations. Because our data are 
cross-sectional, limited inferences can be made regarding 
causality in combined H. pylori and C. pneumoniae infection 
in the development of high blood pressure. We conducted 
our study in a large, random population and used seroposi-
tivity as a marker for infections. Our study has the advan-
tage of clinical applicability, but the assessment of infection 
status based on serology without further clinical or labora-
tory characterization is subject to diagnostic inaccuracies, 
especially if seropositivity is common because of widespread 
distribution of the microorganism in question. In our study, 
the presence of seropositivity to other confounding viral or 
bacterial pathogens cannot be ruled out. Furthermore, the 
measurement of additional atherosclerotic biological mark-
ers and cytokines merits consideration to elucidate the com-
plexity that may underlie the interplay among infectious 
agents, inflammation, molecular mimicry, and structural 
changes in the arteries.
In conclusion, our study failed to show any significant 
association between burden of common viral and bacterial 
infectious pathogens that had been previously associated with 
human coronary atherosclerotic changes as well as carotid 
atherosclerosis and hypertension in a large, representative 
sample of Iranians. Although further studies using diverse 
populations are necessary to confirm our findings, our study 
refutes the hypothesis that the risk of essential hyperten-
sion is associated with aggregated pathogen load.15 However, 
coinfection with H. pylori and C. pneumoniae appears to be 
associated with essential hypertension independently of con-
ventional cardiovascular risk factors and hs-CRP levels.
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